KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.90 $2.68 Friday, 26th Apr 2024 FGEN stock ended at $1.04. This is 1.96% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.67% from a day low at $0.98 to a day high of $1.06.
90 days $0.88 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Apr 12, 2016 $20.50 $20.97 $19.78 $20.54 441 216
Apr 11, 2016 $21.42 $21.72 $20.27 $20.30 523 485
Apr 08, 2016 $21.83 $22.00 $20.77 $21.26 388 586
Apr 07, 2016 $21.88 $22.60 $21.04 $21.31 526 022
Apr 06, 2016 $20.88 $22.23 $20.71 $22.15 584 560
Apr 05, 2016 $20.87 $21.59 $20.48 $20.79 405 642
Apr 04, 2016 $21.00 $21.83 $20.82 $21.00 528 149
Apr 01, 2016 $20.88 $21.57 $20.38 $21.33 354 793
Mar 31, 2016 $20.61 $21.63 $20.46 $21.29 458 727
Mar 30, 2016 $20.00 $20.89 $19.79 $20.71 354 875
Mar 29, 2016 $18.70 $20.00 $18.16 $19.91 419 100
Mar 28, 2016 $19.34 $19.56 $18.91 $19.02 343 400
Mar 24, 2016 $18.57 $20.30 $18.50 $19.21 480 200
Mar 23, 2016 $19.13 $19.54 $18.64 $18.82 791 100
Mar 22, 2016 $18.36 $19.14 $18.22 $19.12 389 100
Mar 21, 2016 $17.57 $18.96 $17.53 $18.58 556 000
Mar 18, 2016 $16.59 $17.71 $16.22 $17.63 867 700
Mar 17, 2016 $17.11 $17.39 $15.52 $16.48 685 000
Mar 16, 2016 $17.56 $17.89 $16.43 $17.08 415 600
Mar 15, 2016 $19.05 $19.18 $17.39 $17.43 523 400
Mar 14, 2016 $18.56 $19.84 $18.32 $19.48 390 200
Mar 11, 2016 $17.96 $18.71 $17.86 $18.60 491 200
Mar 10, 2016 $18.60 $19.17 $17.43 $17.83 268 400
Mar 09, 2016 $18.57 $19.04 $17.01 $18.50 474 900
Mar 08, 2016 $20.11 $20.43 $18.45 $18.53 435 000
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT